Formus Labs has successfully raised $5 million to enhance its automated orthopedic surgery planning platform and establish a partnership with Zimmer Biomet for global market expansion.

Target Company Overview

Formus Labs, headquartered in Auckland, New Zealand, is a pioneering company in the field of orthopedic surgery planning. It has developed the world’s first automated 3D planning software tailored specifically for joint replacement surgeries. The Formus platform integrates artificial intelligence and biomechanics to provide orthopedic surgeons with fully interactive 3D models, enhancing the preoperative planning process and optimizing outcomes for patients.

This innovative software not only automates the planning stages but also enables surgeons to create personalized surgical plans tailored to the unique anatomy of each patient. By significantly improving efficiency, Formus Labs aims to address the notable challenges faced in joint replacement procedures, such as variability in outcomes and the high costs associated with revision surgeries.

Industry Overview in New Zealand

The orthopedic surgical market in New Zealand is a critical segment of the healthcare sector, driven by an increasing aging population and a rising prevalence of conditions requiring joint replacements. An estimated one in five knee

View Source

Similar Deals

Movac Avasa

2025

Seed Stage Medical Devices & Implants New Zealand
Pacific Channel CertusBio

2023

Seed Stage Biotechnology & Medical Research (NEC) New Zealand
Pacific Channel Upstream Medical Technologies

2023

Seed Stage Medical Diagnostic & Testing Equipment New Zealand
Blackbird NZ Fund Carepatron

2023

Seed Stage Telemedicine Services New Zealand
NZVC Bovonic

2023

Seed Stage Bio Medical Devices New Zealand
Even Capital Daisy Lab

Seed Stage Biotechnology & Medical Research (NEC) New Zealand

GD1

invested in

Formus Labs

in 2023

in a Seed Stage deal

Disclosed details

Transaction Size: $5M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert